Caterina Marchiò

<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

Nicholas C. Turner, Alex Pearson, Rachel Sharpe et al. · Cancer Research · 2010 · 738 citations · Full text

Medicine, Cancer Biology, Oncology +17

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

David S.P. Tan, Caterina Marchiò, Robin L. Jones et al. · Breast Cancer Research and Treatment · 2007 · 319 citations

Medicine, Molecular Medicine, Oncology +17

Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial

Andrea Sartore‐Bianchi, Filippo Pietrantonio, Sara Lonardi et al. · Nature Medicine · 2022 · 261 citations · Full text

Medicine, Oncology, Pharmacology +17

Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands

Ilan Weinreb, Salvatore Piscuoglio, Luciano G. Martelotto et al. · Nature Genetics · 2014 · 213 citations · Full text

Medicine, Oncology, Pathology +16

Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence <i>in situ</i> hybridization and microarray‐based CGH analysis

Caterina Marchiò, Maryou Lambros, Patrizia Gugliotta et al. · The Journal of Pathology · 2009 · 201 citations · Full text

Life Sciences, Genetics, Oncology +16